Massmart Presentation on Medicines and Related Substances Amendment Bill, 2008 Presentation by Graham Rebello Massmart Channel Executive.

Slides:



Advertisements
Similar presentations
Channels of Distribution Getting goods to the consumer.
Advertisements

Debby Shapero Propp CESO 2004 April 30, 2004 TREATMENT OF MEDICAL DEVICE LICENSING ISSUES IN PROCUREMENT DOCUMENTATION.
Section 21.2 Distribution Planning
KEY TERMS UNIT 4 (DISTRIBUTION) Marketing. GETTING PRODUCTS TO THE CUSTOMERS; HELPING CUSTOMERS FIND AND GET PRODUCTS. Distribution (Place) #1 SHOWNEXT.
POULTRY BRINE INJECTION DAFF AND DTI PRESENTATION Dr. NTSHABELE DIRECTOR: FOOD SAFETY AND QUALITY ASSURANCE PORTFOLIO COMMITTEE ON AGRICULTURE, FORESTRY.
25-1 Chapter 44 Consumer Protection and Product Safety.
Wel come.
RETAIL MANAGEMENT AN INTRODUCTION.
Name the five marketing strategies that make up the marketing mix.
Medicines & Related Substances Amendment Bill: Protecting the Nation’s Health “The State must take reasonable legislative and other measures, within its.
Form 4 Commercial studies
Food Laws and the Market and Distribution Systems Chapter 2.
Presented by: George Howe Executive Vice President Business Development & OEM Accounts.
Regulations Relating to Foodstuffs for Infants and Young Children (Foodstuffs, Cosmetics and Disinfectants Act, 1972) Briefing to the Portfolio Committee.
Canada Consumer Product Safety Act An Overview Graham Stewart Health Canada.
Components of the Distribution Channel Wholesalers Retailers
Debby Shapero Propp CESO 2004 April 30, 2004 TREATMENT OF MEDICAL DEVICE LICENSING ISSUES IN PROCUREMENT DOCUMENTATION.
Joint comment by The Nutrition Society of South Africa Association for Dietetics in South Africa Presented by Prof Johann Jerling Medicines and Related.
The Pharmaceutical Industry in Turkey
Chain of Productions and Channels of Distribution
Wholesaling Encompasses the buying and/or handling of good and services and their subsequent resale to organizational users, retailers, and/or other wholesalers-
EXPERIENCES IN SOUTH AFRICA WITH THE INTRODUCTION OF PHARMACEUTICAL PRICING LEGISLATION Zokufa HZ, Pillay T Pharmaceutical Policy and Planning, Department.
SALDA Presentation to the Honourable Portfolio Committee on Health National Health Act Amendment Bill B March 2012.
Presented by J F Luterek, Pr.Eng Hahn & Hahn Attorneys
Marketing Mix ProductPromotionPricePlace. PLACE This is also called ‘Distribution’. A business must get the product to the right place, at the right time.
Latest in Health Law…. SAPRAA June Key pieces of legislation Health Charter & BB BEE Medicines & Related Substance Act, regulations & Code Medical.
MGT-519 STRATEGIC MARKETING AAMER SIDDIQI 1. LECTURE 22 2.
1 1 © F-D & B, 2002 BALKAN LEGAL FORUM 2002 SOFIA, BULGARIA Dr. Jürgen Brandstätter ADVERTISING ACTIVITIES IN THE LIGHT OF EUROPEAN LAW STANDARDS.
Distribution Notes Channels of Distribution. Channel of Distribution The pathway from a producer/manufacturer to the final user Manufacturer Middlemen.
Making false claims about medicines - selling, advertising Enforcing the law Fatima Hassan Senior Attorney 26 September 2006.
Amendment Bill 6 of 2014 Briefing to the Portfolio Committee 26 th November 2014.
DISCOVERY HEALTH COMMENTS ON THE MEDICINES AND RELATED SUBSTANCES BILL August 2008.
CGCSA Legal & Regulatory Affairs 1 PRESENTATION BY CONSUMER GOODS COUNCIL OF SOUTH AFRICA ON: Proposed Medicines and Related Substances Amendment Bill.
Portfolio Committee on Health Medicine Prices Regulations 17 February 2004 Dr HZ Zokufa.
© 2010 Pearson Education, Inc., publishing as Prentice-Hall 1 CONSUMER PROTECTION AND PRODUCT SAFETY © 2010 Pearson Education, Inc., publishing as Prentice-Hall.
Portfolio Committee for Health Medicines and Related Substances Amendment Bill (06/08/08) IMSA represents Research Based Pharmaceutical Companies.
Where do products come from?
Channels of Distribution Lec: 1. Marketing Channels Structure and Functions.
Aspects of the placement decision
Fashion Businesses MKT-FMRE-8 Understand the concepts and processes needed to obtain, develop, maintain, and improve a product mix in response to market.
2 2 distribution Components to distribution physically distributing goods through those channels selecting, developing, and managing distribution channels.
CHANNEL INSTITUTIONS- WHOLESALING
© 2007 Prentice Hall, Business Law, sixth edition, Henry R. Cheeseman Consumer Protection.
The community pharmacy environment HMI Public Hearing Set 1 Hearing 2
1 Unit 2 -- Distribution. 2 Unit Objectives b Define channels of distribution. b Identify channel members. b Describe merchant intermediaries. b List.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
Distillery Licenses in Oregon presented by Linda Ignowski Regulatory Services Director March 9, 2010.
Distribution Where do products come from?. Channels of Distribution The path from manufacturer to the final user Business – industrial user Person - consumer.
The Law of the KR «On making amendments and changes to certain legislative acts of the KR» 4 th MeTA Forum in the Kyrgyz Republic Bishkek, December 8,
PRESENTATION BY CONSUMER GOODS COUNCIL OF SOUTH AFRICA ON:
Medicines Control Council (MCC) &
Fashion Merchandising 2.01B
Fashion Merchandising 2.01
The Marketing Mix Place.
THE SELF MEDICATION MANUFACTURERS ASSOCIATION OF SOUTH AFRICA (SMASA)
Chain of production and channels of distribution
INTERNATIONAL PRICING ACTIVITIES
Chain of Productions and Channels of Distribution
Global Pricing and Distribution Strategies
Chain of Productions and Channels of Distribution
Channels of Distribution
Medicines Control Council (MCC) &
BS EN 10204:2004 Metallic Products – Types of inspection documents
BS EN 10204:2004 Metallic Products – Types of inspection documents
Medicines and Related Substances Amendment Bill RETAILERS’ ASSOCIATION Health Portfolio Committee, 6 August 2008.
Channels of Distribution
Amendments effected to the Liquor Bill, 2003
Trade Profile | Organisational Structure | 2018
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
Access to Cannabis for Medicinal and Research Purposes
Presentation transcript:

Massmart Presentation on Medicines and Related Substances Amendment Bill, 2008 Presentation by Graham Rebello Massmart Channel Executive

The Massmart Portfolio MASSMART HOLDINGS 243 Stores MASSDISCOUNTERS GM discounters >LSM stores MASSWAREHOUSE Warehouse Club > LSM stores MASSBUILD DIY HI Outlets > LSM stores MASSCASH Food cash & carry > LSM stores members

“Foodstuff” & “Cosmetic” Foodstuffs, Cosmetics and Disinfectants Act and Regulations thereunder –Directorate of Food Control –Current food labelling regulations GNR2034/ Labelling and Advertising of Foodstuffs, Regulation 2(9)(c) prohibits use of words such as ‘heal’, ‘cure’, ‘restorative’, or any other medicinal, therapeutic or prophylactic claim. –Proposed Food labelling regulations published 07/2007: Regulation 14(k) prohibits use of the word ‘cure’ or any other medicinal claim except those health claims permitted in terms of these regulations. See Reg 62 -Nutritional Supplements regulations currently being prepared by Directorate of Food Control which will regulate all aspects of supplements.

Foodstuffs & Cosmetics – “products” Medicines and Related Substances Act –Regulates medicines and related substances –Now: Bill introduces foodstuffs & cosmetics if “medicinal claims are made” – no definition creates confusion? Regulatory enforcement Manufacturers and importer compliance Wholesalers and Retailers compliance Customer issues / awareness –Lead to uncertainty and duplication of functions of various directorates within the Department of Health –“Food Control” should be in control of claims made in respect of foods?

Wholesaler Massmart are “wholesalers” in the broad meaning of the word and by definition within GN R510 of 10 th April 2003 – “"wholesaler" means a dealer who purchases medicines from a manufacturer and sells them to a retailer and includes a wholesale pharmacy;” : –Jumbo sells foodstuffs, cosmetics, and OTC medicines to both the public directly (consumers) and to independent retailers (commercial). –The wording of Section 22H of the Act, should be redrafted to exclude Cash and Carry wholesalers who sell general consumer goods to consumers on demand from the definition of "wholesaler". –Accordingly a definition of wholesaler should be introduced and an amendment to Section 22H is proposed (Section 27 of the Amendment Bill).

Schedule 0, Complementary and Unregistered Medicines Schedule 0, Unregistered and Complementary Medicines are like other fast moving consumer goods –Highly competitive market because of extensive sales channels through companies like Massmart –Competition is healthy and the consumer effectively dictates prices in a highly competitive market –Advantageous for the poor who can’t afford to consult doctors but need simple medication for ailments –Sold widely to spaza shops and small retailers for resale in small quantities to the public, especially in rural areas. Exemption from Sections 18A and 22G of the Act (prior to amendment) must be made explicit in the Bill

Unforeseen Consequences Many of Massmart’s outlets are located in rural areas and serve rural communities Supply spaza shops and small retailers as well as the public directly (bulk purchases) Massmart would have to discontinue entire ranges of products so as not fall foul of the Bill either because of the lack of definition of “wholesaler” and “medicinal claim” fortified maize and wheat, margarines claiming to reduce cholesterol etc could be considered medicines Spaza and small retailers would be unable to source these products and the rural consumer would be unable to obtain such products which would only be stocked in pharmacies

Submissions Introduce a definition of “wholesaler” which clarifies the position of companies such as Massmart Exclude all foodstuffs and cosmetics from the Bill Alternatively: –adopt a definition for “medicinal claims”. –Amend Section 27 of the Bill (Section 22H of the Act) to remove unforeseen consequences around wholesalers selling foodstuffs –Amend Section 7 of the Bill (Section 15(7) of the Act) to reduce the administrative burden on small companies which manufacture foodstuffs considered to fall under the Bill

Proposed Amendments Proposed New Definitions –“medicinal claims” – claims directed at healing or curative properties or attributes of the human body by a foodstuff or cosmetic; –“wholesaler” – entity which distributes or sells medicines and/or medical devices solely to the retail, but excluding general merchandise and food wholesalers;

Proposed Amendment Section 27 (22H of the Act) (1)(a) No wholesaler shall purchase [medicines] products medicines or medical devices from any source other than the original manufacturer or from the primary importer of the finished product. (b) A wholesaler shall sell [medicines] products medicines or medical devices only into the retail sector. Section 7 of the Bill (15(7) of the Act) Any certification or registration under this section, shall be valid for a period of five years in the case of medicines and medical devices and indefinitely until revoked in the case of cosmetics and foodstuffs and may be made subject to such condition as may with regard to the succeeding provisions of this section to be determined by the Authority or the Minister respectively.